Results 191 to 200 of about 185,904 (310)

Myocarditis Revealing Acute Myeloid Leukemia in a Young Adolescent. [PDF]

JACC Case Rep
Haboub M, Bargach K, Bouziane M.
europepmc   +1 more source

Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5 [PDF]

, 1996
Hélène A. Poirel, Katrina Rack, Éric Delabesse, I Radford-Weiss, Xavier Troussard, C Debert, D Leboeuf, Christian Bastard, Françoise Picard, A Veil-Buzyn, Georges Flandrin, Olivier Bernard, Elizabeth Macintyre   +12 more
openalex   +1 more source

Hemophagocytosis in acute myeloid leukemia

Hematology, Transfusion and Cell Therapy
Claudia Morales-Olvera, Fernando Pérez-Jacobo   +1 more
openaire   +3 more sources

Combined Immediate‐Release and Extended‐Release Formulation of Sodium Valproate Provides Stable Plasma Levels for Inhibition of Histone Deacetylation

Clinical Pharmacology in Drug Development, EarlyView.
Abstract A modified controlled‐release sodium valproate formulation (VAL001, test) was compared with an approved enteric‐coated tablet formulation (Absenor, reference). Pharmacokinetics and safety/tolerability were evaluated in healthy subjects to bridge with positive efficacy results from an early‐phase patient trial of valproate in combination with ...
Nikhil Ahuja, Susanna Kääriäinen, Zsófia Lovró, Mia Lundblad, Kristina Drott, Elsa Lilienberg, Marica T. Engström, Karla Saukkonen, Mika Scheinin   +8 more
wiley   +1 more source

Microbiome‐Informed Dosing: Exploring Gut Microbial Communities Impact on Mycophenolate Enterohepatic Circulation and Therapeutic Target Achievement

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacomicrobiomics is an emerging field due to important microbiome effects on pharmacokinetics and clinical outcomes. However, the application of this knowledge remains limited. Mycophenolic acid (MPA) is the primary active metabolite of the immunosuppressant, mycophenolate mofetil (MMF).
Abdelrahman Saqr, Shen Cheng, Mahmoud Al‐Kofahi, Christopher Staley, Pamala A. Jacobson   +4 more
wiley   +1 more source

CD155 as a prognostic and predictive biomarker in acute myeloid leukemia. [PDF]

Discov Oncol
Abdalla AZ, Khallaf SM, Zahran AM, Rayan NA, Elzaher ARA.   +4 more
europepmc   +1 more source

Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia [PDF]

, 1996
Konstanze Fischer, Catharina Scholl, J Salat, Stefan Fröhling, Richard F. Schlenk, Martin Bentz, Stephan Stilgenbauer, Peter Lichter, H. Döhner   +8 more
openalex   +1 more source

Critical Pitfalls in the Flow Cytometric Analysis of Mast Cells in Patients With Systemic Mastocytosis

Cytometry Part A, EarlyView.
ABSTRACT Systemic mastocytosis (SM) is a neoplastic disease characterized by abnormal mast cell (MC) activation and proliferation. Accurate diagnosis often relies on flow cytometry to detect aberrant CD25, CD2, and CD30 expression on MCs in bone marrow (BM).
Abdulrazzaq Alheraky, Kees Meijer, Marije T. Nijk, Saskia K. Klein, Hanneke N. G. Oude Elberink, Ido P. Kema, André B. Mulder   +6 more
wiley   +1 more source

Congenital Acute Myeloid Leukemia (AML): A Case Report. [PDF]

Int Med Case Rep J
Alsharidah S, Almatar E.
europepmc   +1 more source

Modulation of Idarubicin-Induced Apoptosis in Human Acute Myeloid Leukemia Blasts by All-Trans Retinoic Acid, 1,25(OH)2 Vitamin D3, and Granulocyte-Macrophage Colony-Stimulating Factor [PDF]

, 1997
Nicolas J. Ketley, Paul Allen, Stephen M. Kelsey, Adrian C. Newland   +3 more
openalex   +1 more source